Monograph Details
|
|
Musculoskeletal Disorders
> Bone disorders
|
|
ACTONEL WITH CALCIUM |
| Manufacturer |
|
Procter & Gamble Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Bisphosphonate + calcium. |
| Generic Name |
|
Risedronate (as sodium) 35mg (4 tabs); calcium, elemental (as carbonate) 500mg (24 tabs); per pack. |
| Also |
|
• ACTONEL
|
| Indications |
|
Prevention and treatment of osteoporosis in postmenopausal women. |
| Children |
|
Not recommended. |
| Adults |
|
Risedronate: Swallow whole; take in the AM with a full glass (6–8 oz) plain (not mineral) water at least 30 minutes before other food or drink; take in upright position; do not lie down for at least 30 minutes afterwards. 35mg risedronate once weekly on day 1 then 500mg calcium once daily with food on days 2–7 each week. |
| Contraindications |
|
Inability to stand or sit upright for at least 30 minutes. Hypocalcemia. Calcium: also hypercalcemia. |
| Precautions |
|
Upper GI disease. Severe renal impairment (CrCl <30mL/min): not recommended. Correct preexisting hypocalcemia, other mineral or bone disturbances before starting. Obtain and correct sex steroid hormonal status before initiating therapy in glucocorticoid-induced osteoporosis. Ensure adequate Vit. D and calcium intake. Reevaluate if esophageal reaction occurs. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Risedronate: calcium, aluminum, magnesium, other divalent cations reduce absorption (separate dosing). Caution with other GI irritants. May interfere with bone-imaging agents. Calcium: blocks tetracycline, levothyroxine, fluoroquinolone absorption. Calcium absorption decreased by glucocorticoids. |
| Adverse Reactions |
|
GI upset, abdominal pain, musculoskeletal pain (may be severe), others; rarely: dysphagia, esophagitis, gastric ulcer, jaw osteonecrosis. Calcium: also hypercalciuria, hypercalcemia. |
| How Supplied |
Tabs 5mg, 30mg—30
35mg—4, 12
75mg—2
150mg—1, 3
Actonel w. Calcium—1 pack (4 week supply) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
